Brazil’s medtech regulator hammers home its key industry role
This article was originally published in Clinica
Executive Summary
Brazil’s healthcare products regulatory agency, Anvisa, is claiming a central role in the country's medtech innovation drive. The rapid deployment of products that are likely to have a significant impact on industrial and economic development is one area in which it can help, it believes.